Tamsulosin Hydrochloride Capsule
Product Images NDC 51407-879

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 51407-879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-879-90lb (Tamsulosin HCI 0.4 mg)

Label for Tamsulosin Hydrochloride 0.4 mg capsules, USP in a 90-capsule package by Golden State Medical Supply, Inc. The label includes dosage strength, storage instructions, and a barcode. It notes the medication is prescription only and provides a patient information website and safety warnings on moisture and child safety.*

FDA Label Image

Tamsulosin-figure1 (Tamsulosin Figure1)

A line graph showing plasma concentration (ng/mL) over time (hours) comparing 'Fasted' and 'Fed' conditions. The 'Fasted' condition shows a sharper peak in plasma concentration earlier than the 'Fed' condition, which has a lower but more sustained concentration over time.*

FDA Label Image

Tamsu-fi2a (Tamsulosin Figure2a)

A line graph showing mean change over duration of treatment in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The y-axis represents the mean change, ranging from 0 to -11, and the x-axis represents treatment duration from baseline to 13 weeks and LOCF (last observation carried forward) timepoints. The graph compares treatment effects with mean change decreasing over time for both doses compared to placebo.*

FDA Label Image

Tamsu-fig2b (Tamsulosin Figure2b)

A line graph showing mean change over a treatment duration of 13 weeks plus a last observation carried forward (LOCF) time point. It compares the effects of Tamsulosin Hydrochloride capsules at 0.8 mg and 0.4 mg dosages versus a placebo, with the y-axis representing mean change and the x-axis representing treatment duration in weeks. Sample sizes at various weeks are indicated.*

FDA Label Image

Tamsu-fig3a (Tamsulosin Figure3a)

A line graph depicting mean change in urinary flow rate (mL/sec) over a 13-week treatment period for three groups: Tamsulosin Hydrochloride 0.8 mg, 0.4 mg, and placebo. The graph shows treatment effects over time with separate lines for each group.*

FDA Label Image

Tamsu-fig3b (Tamsulosin Figure3b)

A line graph depicting mean change in a value (mL/sec) over duration of treatment in weeks for three groups: 0.8 mg dose, 0.4 mg dose, and placebo. The x-axis represents treatment duration from 0 to 13 weeks, and the y-axis shows mean change from 0 to 3.0 mL/sec. The 0.8 mg group shows the highest early increase, followed by the 0.4 mg group, with the placebo group showing the lowest increase over time.*

FDA Label Image

Tamsulosin-structure (Tamsulosin Structure)

Chemical structure diagram of Tamsulosin Hydrochloride showing its molecular framework including aromatic rings, functional groups, and the hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.